nodes	percent_of_prediction	percent_of_DWPC	metapath
Guaifenesin—Discomfort—Bleomycin—hematologic cancer	0.00396	0.00396	CcSEcCtD
Guaifenesin—Nausea—Methoxsalen—hematologic cancer	0.00396	0.00396	CcSEcCtD
Guaifenesin—Urticaria—Chlorambucil—hematologic cancer	0.00394	0.00394	CcSEcCtD
Guaifenesin—Vomiting—Idarubicin—hematologic cancer	0.0039	0.0039	CcSEcCtD
Guaifenesin—Discomfort—Vinorelbine—hematologic cancer	0.0039	0.0039	CcSEcCtD
Guaifenesin—Rash—Idarubicin—hematologic cancer	0.00386	0.00386	CcSEcCtD
Guaifenesin—Dermatitis—Idarubicin—hematologic cancer	0.00386	0.00386	CcSEcCtD
Guaifenesin—Urticaria—Nilotinib—hematologic cancer	0.00386	0.00386	CcSEcCtD
Guaifenesin—Nausea—Mercaptopurine—hematologic cancer	0.00385	0.00385	CcSEcCtD
Guaifenesin—Headache—Idarubicin—hematologic cancer	0.00384	0.00384	CcSEcCtD
Guaifenesin—Urticaria—Imatinib—hematologic cancer	0.00384	0.00384	CcSEcCtD
Guaifenesin—Nausea—Daunorubicin—hematologic cancer	0.00379	0.00379	CcSEcCtD
Guaifenesin—Nausea—Clofarabine—hematologic cancer	0.00379	0.00379	CcSEcCtD
Guaifenesin—Vomiting—Teniposide—hematologic cancer	0.00379	0.00379	CcSEcCtD
Guaifenesin—Nausea—Anagrelide—hematologic cancer	0.00378	0.00378	CcSEcCtD
Guaifenesin—Nausea—Pentostatin—hematologic cancer	0.00378	0.00378	CcSEcCtD
Guaifenesin—Urticaria—Cladribine—hematologic cancer	0.00377	0.00377	CcSEcCtD
Guaifenesin—Rash—Teniposide—hematologic cancer	0.00376	0.00376	CcSEcCtD
Guaifenesin—Dermatitis—Teniposide—hematologic cancer	0.00376	0.00376	CcSEcCtD
Guaifenesin—Headache—Teniposide—hematologic cancer	0.00374	0.00374	CcSEcCtD
Guaifenesin—Dizziness—Busulfan—hematologic cancer	0.00365	0.00365	CcSEcCtD
Guaifenesin—Nausea—Idarubicin—hematologic cancer	0.00364	0.00364	CcSEcCtD
Guaifenesin—Discomfort—Thalidomide—hematologic cancer	0.0036	0.0036	CcSEcCtD
Guaifenesin—Dizziness—Procarbazine—hematologic cancer	0.00354	0.00354	CcSEcCtD
Guaifenesin—Nausea—Teniposide—hematologic cancer	0.00354	0.00354	CcSEcCtD
Guaifenesin—Vomiting—Busulfan—hematologic cancer	0.00351	0.00351	CcSEcCtD
Guaifenesin—Rash—Busulfan—hematologic cancer	0.00348	0.00348	CcSEcCtD
Guaifenesin—Dermatitis—Busulfan—hematologic cancer	0.00348	0.00348	CcSEcCtD
Guaifenesin—Dizziness—Bexarotene—hematologic cancer	0.00348	0.00348	CcSEcCtD
Guaifenesin—Dizziness—Dasatinib—hematologic cancer	0.00348	0.00348	CcSEcCtD
Guaifenesin—Headache—Busulfan—hematologic cancer	0.00346	0.00346	CcSEcCtD
Guaifenesin—Urticaria—Melphalan—hematologic cancer	0.00344	0.00344	CcSEcCtD
Guaifenesin—Discomfort—Alitretinoin—hematologic cancer	0.00342	0.00342	CcSEcCtD
Guaifenesin—Vomiting—Procarbazine—hematologic cancer	0.00341	0.00341	CcSEcCtD
Guaifenesin—Discomfort—Ifosfamide—hematologic cancer	0.00338	0.00338	CcSEcCtD
Guaifenesin—Rash—Procarbazine—hematologic cancer	0.00338	0.00338	CcSEcCtD
Guaifenesin—Dermatitis—Procarbazine—hematologic cancer	0.00338	0.00338	CcSEcCtD
Guaifenesin—Headache—Procarbazine—hematologic cancer	0.00336	0.00336	CcSEcCtD
Guaifenesin—Urticaria—Lenalidomide—hematologic cancer	0.00334	0.00334	CcSEcCtD
Guaifenesin—Vomiting—Bexarotene—hematologic cancer	0.00334	0.00334	CcSEcCtD
Guaifenesin—Vomiting—Dasatinib—hematologic cancer	0.00334	0.00334	CcSEcCtD
Guaifenesin—Vomiting—Fludarabine—hematologic cancer	0.00333	0.00333	CcSEcCtD
Guaifenesin—Rash—Bexarotene—hematologic cancer	0.00331	0.00331	CcSEcCtD
Guaifenesin—Rash—Dasatinib—hematologic cancer	0.00331	0.00331	CcSEcCtD
Guaifenesin—Dermatitis—Dasatinib—hematologic cancer	0.00331	0.00331	CcSEcCtD
Guaifenesin—Dermatitis—Bexarotene—hematologic cancer	0.00331	0.00331	CcSEcCtD
Guaifenesin—Rash—Fludarabine—hematologic cancer	0.0033	0.0033	CcSEcCtD
Guaifenesin—Dermatitis—Fludarabine—hematologic cancer	0.0033	0.0033	CcSEcCtD
Guaifenesin—Headache—Dasatinib—hematologic cancer	0.00329	0.00329	CcSEcCtD
Guaifenesin—Headache—Bexarotene—hematologic cancer	0.00329	0.00329	CcSEcCtD
Guaifenesin—Headache—Fludarabine—hematologic cancer	0.00328	0.00328	CcSEcCtD
Guaifenesin—Nausea—Busulfan—hematologic cancer	0.00328	0.00328	CcSEcCtD
Guaifenesin—Discomfort—Mitoxantrone—hematologic cancer	0.00321	0.00321	CcSEcCtD
Guaifenesin—Discomfort—Irinotecan—hematologic cancer	0.00321	0.00321	CcSEcCtD
Guaifenesin—Dizziness—Nilotinib—hematologic cancer	0.00321	0.00321	CcSEcCtD
Guaifenesin—Dizziness—Imatinib—hematologic cancer	0.00319	0.00319	CcSEcCtD
Guaifenesin—Nausea—Procarbazine—hematologic cancer	0.00318	0.00318	CcSEcCtD
Guaifenesin—Vomiting—Chlorambucil—hematologic cancer	0.00316	0.00316	CcSEcCtD
Guaifenesin—Dizziness—Cladribine—hematologic cancer	0.00314	0.00314	CcSEcCtD
Guaifenesin—Discomfort—Gemcitabine—hematologic cancer	0.00313	0.00313	CcSEcCtD
Guaifenesin—Nausea—Dasatinib—hematologic cancer	0.00312	0.00312	CcSEcCtD
Guaifenesin—Nausea—Bexarotene—hematologic cancer	0.00312	0.00312	CcSEcCtD
Guaifenesin—Nausea—Fludarabine—hematologic cancer	0.00311	0.00311	CcSEcCtD
Guaifenesin—Vomiting—Nilotinib—hematologic cancer	0.00309	0.00309	CcSEcCtD
Guaifenesin—Urticaria—Bortezomib—hematologic cancer	0.00308	0.00308	CcSEcCtD
Guaifenesin—Vomiting—Imatinib—hematologic cancer	0.00307	0.00307	CcSEcCtD
Guaifenesin—Rash—Nilotinib—hematologic cancer	0.00306	0.00306	CcSEcCtD
Guaifenesin—Dermatitis—Nilotinib—hematologic cancer	0.00306	0.00306	CcSEcCtD
Guaifenesin—Urticaria—Bleomycin—hematologic cancer	0.00305	0.00305	CcSEcCtD
Guaifenesin—Rash—Imatinib—hematologic cancer	0.00304	0.00304	CcSEcCtD
Guaifenesin—Headache—Nilotinib—hematologic cancer	0.00304	0.00304	CcSEcCtD
Guaifenesin—Dermatitis—Imatinib—hematologic cancer	0.00304	0.00304	CcSEcCtD
Guaifenesin—Headache—Imatinib—hematologic cancer	0.00302	0.00302	CcSEcCtD
Guaifenesin—Vomiting—Cladribine—hematologic cancer	0.00302	0.00302	CcSEcCtD
Guaifenesin—Dizziness—Vinblastine—hematologic cancer	0.00301	0.00301	CcSEcCtD
Guaifenesin—Urticaria—Vinorelbine—hematologic cancer	0.003	0.003	CcSEcCtD
Guaifenesin—Rash—Cladribine—hematologic cancer	0.00299	0.00299	CcSEcCtD
Guaifenesin—Dermatitis—Cladribine—hematologic cancer	0.00299	0.00299	CcSEcCtD
Guaifenesin—Headache—Cladribine—hematologic cancer	0.00297	0.00297	CcSEcCtD
Guaifenesin—Nausea—Chlorambucil—hematologic cancer	0.00295	0.00295	CcSEcCtD
Guaifenesin—Discomfort—Cisplatin—hematologic cancer	0.00292	0.00292	CcSEcCtD
Guaifenesin—Vomiting—Vinblastine—hematologic cancer	0.00289	0.00289	CcSEcCtD
Guaifenesin—Nausea—Nilotinib—hematologic cancer	0.00288	0.00288	CcSEcCtD
Guaifenesin—Urticaria—Thiotepa—hematologic cancer	0.00287	0.00287	CcSEcCtD
Guaifenesin—Nausea—Imatinib—hematologic cancer	0.00287	0.00287	CcSEcCtD
Guaifenesin—Headache—Vinblastine—hematologic cancer	0.00285	0.00285	CcSEcCtD
Guaifenesin—Nausea—Cladribine—hematologic cancer	0.00282	0.00282	CcSEcCtD
Guaifenesin—Dizziness—Lenalidomide—hematologic cancer	0.00278	0.00278	CcSEcCtD
Guaifenesin—Urticaria—Thalidomide—hematologic cancer	0.00277	0.00277	CcSEcCtD
Guaifenesin—Vomiting—Melphalan—hematologic cancer	0.00275	0.00275	CcSEcCtD
Guaifenesin—Dizziness—Hydroxyurea—hematologic cancer	0.00274	0.00274	CcSEcCtD
Guaifenesin—Rash—Melphalan—hematologic cancer	0.00273	0.00273	CcSEcCtD
Guaifenesin—Dermatitis—Melphalan—hematologic cancer	0.00273	0.00273	CcSEcCtD
Guaifenesin—Nausea—Vinblastine—hematologic cancer	0.0027	0.0027	CcSEcCtD
Guaifenesin—Vomiting—Lenalidomide—hematologic cancer	0.00268	0.00268	CcSEcCtD
Guaifenesin—Discomfort—Etoposide—hematologic cancer	0.00267	0.00267	CcSEcCtD
Guaifenesin—Rash—Lenalidomide—hematologic cancer	0.00265	0.00265	CcSEcCtD
Guaifenesin—Dermatitis—Lenalidomide—hematologic cancer	0.00265	0.00265	CcSEcCtD
Guaifenesin—Urticaria—Alitretinoin—hematologic cancer	0.00264	0.00264	CcSEcCtD
Guaifenesin—Vomiting—Hydroxyurea—hematologic cancer	0.00264	0.00264	CcSEcCtD
Guaifenesin—Discomfort—Prednisolone—hematologic cancer	0.00264	0.00264	CcSEcCtD
Guaifenesin—Headache—Lenalidomide—hematologic cancer	0.00264	0.00264	CcSEcCtD
Guaifenesin—Rash—Hydroxyurea—hematologic cancer	0.00262	0.00262	CcSEcCtD
Guaifenesin—Dermatitis—Hydroxyurea—hematologic cancer	0.00261	0.00261	CcSEcCtD
Guaifenesin—Urticaria—Ifosfamide—hematologic cancer	0.00261	0.00261	CcSEcCtD
Guaifenesin—Headache—Hydroxyurea—hematologic cancer	0.0026	0.0026	CcSEcCtD
Guaifenesin—Nausea—Melphalan—hematologic cancer	0.00257	0.00257	CcSEcCtD
Guaifenesin—Dizziness—Bortezomib—hematologic cancer	0.00256	0.00256	CcSEcCtD
Guaifenesin—Dizziness—Vinorelbine—hematologic cancer	0.0025	0.0025	CcSEcCtD
Guaifenesin—Nausea—Lenalidomide—hematologic cancer	0.0025	0.0025	CcSEcCtD
Guaifenesin—Urticaria—Mitoxantrone—hematologic cancer	0.00248	0.00248	CcSEcCtD
Guaifenesin—Nausea—Hydroxyurea—hematologic cancer	0.00246	0.00246	CcSEcCtD
Guaifenesin—Vomiting—Bortezomib—hematologic cancer	0.00246	0.00246	CcSEcCtD
Guaifenesin—Vomiting—Bleomycin—hematologic cancer	0.00244	0.00244	CcSEcCtD
Guaifenesin—Rash—Bortezomib—hematologic cancer	0.00244	0.00244	CcSEcCtD
Guaifenesin—Dermatitis—Bortezomib—hematologic cancer	0.00244	0.00244	CcSEcCtD
Guaifenesin—Headache—Bortezomib—hematologic cancer	0.00243	0.00243	CcSEcCtD
Guaifenesin—Discomfort—Triamcinolone—hematologic cancer	0.00242	0.00242	CcSEcCtD
Guaifenesin—Rash—Bleomycin—hematologic cancer	0.00242	0.00242	CcSEcCtD
Guaifenesin—Dermatitis—Bleomycin—hematologic cancer	0.00242	0.00242	CcSEcCtD
Guaifenesin—Vomiting—Vinorelbine—hematologic cancer	0.0024	0.0024	CcSEcCtD
Guaifenesin—Dizziness—Thiotepa—hematologic cancer	0.00239	0.00239	CcSEcCtD
Guaifenesin—Rash—Vinorelbine—hematologic cancer	0.00238	0.00238	CcSEcCtD
Guaifenesin—Dermatitis—Vinorelbine—hematologic cancer	0.00238	0.00238	CcSEcCtD
Guaifenesin—Headache—Vinorelbine—hematologic cancer	0.00237	0.00237	CcSEcCtD
Guaifenesin—Dizziness—Thalidomide—hematologic cancer	0.00231	0.00231	CcSEcCtD
Guaifenesin—Nausea—Bortezomib—hematologic cancer	0.0023	0.0023	CcSEcCtD
Guaifenesin—Vomiting—Thiotepa—hematologic cancer	0.0023	0.0023	CcSEcCtD
Guaifenesin—Nausea—Bleomycin—hematologic cancer	0.00228	0.00228	CcSEcCtD
Guaifenesin—Rash—Thiotepa—hematologic cancer	0.00228	0.00228	CcSEcCtD
Guaifenesin—Dermatitis—Thiotepa—hematologic cancer	0.00227	0.00227	CcSEcCtD
Guaifenesin—Headache—Thiotepa—hematologic cancer	0.00226	0.00226	CcSEcCtD
Guaifenesin—Nausea—Vinorelbine—hematologic cancer	0.00225	0.00225	CcSEcCtD
Guaifenesin—Vomiting—Thalidomide—hematologic cancer	0.00222	0.00222	CcSEcCtD
Guaifenesin—Dizziness—Carmustine—hematologic cancer	0.00222	0.00222	CcSEcCtD
Guaifenesin—Rash—Thalidomide—hematologic cancer	0.0022	0.0022	CcSEcCtD
Guaifenesin—Discomfort—Betamethasone—hematologic cancer	0.0022	0.0022	CcSEcCtD
Guaifenesin—Discomfort—Dexamethasone—hematologic cancer	0.0022	0.0022	CcSEcCtD
Guaifenesin—Dermatitis—Thalidomide—hematologic cancer	0.0022	0.0022	CcSEcCtD
Guaifenesin—Dizziness—Alitretinoin—hematologic cancer	0.0022	0.0022	CcSEcCtD
Guaifenesin—Headache—Thalidomide—hematologic cancer	0.00219	0.00219	CcSEcCtD
Guaifenesin—Dizziness—Ifosfamide—hematologic cancer	0.00217	0.00217	CcSEcCtD
Guaifenesin—Nausea—Thiotepa—hematologic cancer	0.00214	0.00214	CcSEcCtD
Guaifenesin—Vomiting—Carmustine—hematologic cancer	0.00213	0.00213	CcSEcCtD
Guaifenesin—Dizziness—Vincristine—hematologic cancer	0.00212	0.00212	CcSEcCtD
Guaifenesin—Rash—Carmustine—hematologic cancer	0.00211	0.00211	CcSEcCtD
Guaifenesin—Dermatitis—Carmustine—hematologic cancer	0.00211	0.00211	CcSEcCtD
Guaifenesin—Vomiting—Alitretinoin—hematologic cancer	0.00211	0.00211	CcSEcCtD
Guaifenesin—Headache—Carmustine—hematologic cancer	0.0021	0.0021	CcSEcCtD
Guaifenesin—Rash—Alitretinoin—hematologic cancer	0.00209	0.00209	CcSEcCtD
Guaifenesin—Dermatitis—Alitretinoin—hematologic cancer	0.00209	0.00209	CcSEcCtD
Guaifenesin—Vomiting—Ifosfamide—hematologic cancer	0.00209	0.00209	CcSEcCtD
Guaifenesin—Headache—Alitretinoin—hematologic cancer	0.00208	0.00208	CcSEcCtD
Guaifenesin—Nausea—Thalidomide—hematologic cancer	0.00207	0.00207	CcSEcCtD
Guaifenesin—Rash—Ifosfamide—hematologic cancer	0.00207	0.00207	CcSEcCtD
Guaifenesin—Dermatitis—Ifosfamide—hematologic cancer	0.00207	0.00207	CcSEcCtD
Guaifenesin—Dizziness—Irinotecan—hematologic cancer	0.00206	0.00206	CcSEcCtD
Guaifenesin—Urticaria—Etoposide—hematologic cancer	0.00206	0.00206	CcSEcCtD
Guaifenesin—Vomiting—Vincristine—hematologic cancer	0.00204	0.00204	CcSEcCtD
Guaifenesin—Urticaria—Prednisolone—hematologic cancer	0.00203	0.00203	CcSEcCtD
Guaifenesin—Rash—Vincristine—hematologic cancer	0.00202	0.00202	CcSEcCtD
Guaifenesin—Dermatitis—Vincristine—hematologic cancer	0.00202	0.00202	CcSEcCtD
Guaifenesin—Headache—Vincristine—hematologic cancer	0.00201	0.00201	CcSEcCtD
Guaifenesin—Nausea—Carmustine—hematologic cancer	0.00199	0.00199	CcSEcCtD
Guaifenesin—Vomiting—Mitoxantrone—hematologic cancer	0.00198	0.00198	CcSEcCtD
Guaifenesin—Vomiting—Irinotecan—hematologic cancer	0.00198	0.00198	CcSEcCtD
Guaifenesin—Nausea—Alitretinoin—hematologic cancer	0.00197	0.00197	CcSEcCtD
Guaifenesin—Rash—Mitoxantrone—hematologic cancer	0.00197	0.00197	CcSEcCtD
Guaifenesin—Rash—Irinotecan—hematologic cancer	0.00197	0.00197	CcSEcCtD
Guaifenesin—Dermatitis—Mitoxantrone—hematologic cancer	0.00196	0.00196	CcSEcCtD
Guaifenesin—Dermatitis—Irinotecan—hematologic cancer	0.00196	0.00196	CcSEcCtD
Guaifenesin—Headache—Irinotecan—hematologic cancer	0.00195	0.00195	CcSEcCtD
Guaifenesin—Headache—Mitoxantrone—hematologic cancer	0.00195	0.00195	CcSEcCtD
Guaifenesin—Nausea—Ifosfamide—hematologic cancer	0.00195	0.00195	CcSEcCtD
Guaifenesin—Vomiting—Gemcitabine—hematologic cancer	0.00193	0.00193	CcSEcCtD
Guaifenesin—Discomfort—Prednisone—hematologic cancer	0.00192	0.00192	CcSEcCtD
Guaifenesin—Rash—Gemcitabine—hematologic cancer	0.00192	0.00192	CcSEcCtD
Guaifenesin—Dermatitis—Gemcitabine—hematologic cancer	0.00191	0.00191	CcSEcCtD
Guaifenesin—Headache—Gemcitabine—hematologic cancer	0.0019	0.0019	CcSEcCtD
Guaifenesin—Nausea—Vincristine—hematologic cancer	0.0019	0.0019	CcSEcCtD
Guaifenesin—Urticaria—Triamcinolone—hematologic cancer	0.00187	0.00187	CcSEcCtD
Guaifenesin—Nausea—Irinotecan—hematologic cancer	0.00185	0.00185	CcSEcCtD
Guaifenesin—Nausea—Mitoxantrone—hematologic cancer	0.00185	0.00185	CcSEcCtD
Guaifenesin—Nausea—Gemcitabine—hematologic cancer	0.0018	0.0018	CcSEcCtD
Guaifenesin—Vomiting—Cisplatin—hematologic cancer	0.0018	0.0018	CcSEcCtD
Guaifenesin—Rash—Cisplatin—hematologic cancer	0.00178	0.00178	CcSEcCtD
Guaifenesin—Dermatitis—Cisplatin—hematologic cancer	0.00178	0.00178	CcSEcCtD
Guaifenesin—Dizziness—Etoposide—hematologic cancer	0.00172	0.00172	CcSEcCtD
Guaifenesin—Urticaria—Betamethasone—hematologic cancer	0.0017	0.0017	CcSEcCtD
Guaifenesin—Urticaria—Dexamethasone—hematologic cancer	0.0017	0.0017	CcSEcCtD
Guaifenesin—Dizziness—Prednisolone—hematologic cancer	0.00169	0.00169	CcSEcCtD
Guaifenesin—Nausea—Cisplatin—hematologic cancer	0.00168	0.00168	CcSEcCtD
Guaifenesin—Vomiting—Etoposide—hematologic cancer	0.00165	0.00165	CcSEcCtD
Guaifenesin—Rash—Etoposide—hematologic cancer	0.00164	0.00164	CcSEcCtD
Guaifenesin—Dermatitis—Etoposide—hematologic cancer	0.00163	0.00163	CcSEcCtD
Guaifenesin—Headache—Etoposide—hematologic cancer	0.00162	0.00162	CcSEcCtD
Guaifenesin—Rash—Prednisolone—hematologic cancer	0.00161	0.00161	CcSEcCtD
Guaifenesin—Dermatitis—Prednisolone—hematologic cancer	0.00161	0.00161	CcSEcCtD
Guaifenesin—Headache—Prednisolone—hematologic cancer	0.0016	0.0016	CcSEcCtD
Guaifenesin—Discomfort—Methotrexate—hematologic cancer	0.0016	0.0016	CcSEcCtD
Guaifenesin—Dizziness—Triamcinolone—hematologic cancer	0.00156	0.00156	CcSEcCtD
Guaifenesin—Nausea—Etoposide—hematologic cancer	0.00154	0.00154	CcSEcCtD
Guaifenesin—Nausea—Prednisolone—hematologic cancer	0.00152	0.00152	CcSEcCtD
Guaifenesin—Discomfort—Epirubicin—hematologic cancer	0.0015	0.0015	CcSEcCtD
Guaifenesin—Vomiting—Triamcinolone—hematologic cancer	0.0015	0.0015	CcSEcCtD
Guaifenesin—Rash—Triamcinolone—hematologic cancer	0.00148	0.00148	CcSEcCtD
Guaifenesin—Dermatitis—Triamcinolone—hematologic cancer	0.00148	0.00148	CcSEcCtD
Guaifenesin—Urticaria—Prednisone—hematologic cancer	0.00148	0.00148	CcSEcCtD
Guaifenesin—Headache—Triamcinolone—hematologic cancer	0.00147	0.00147	CcSEcCtD
Guaifenesin—Dizziness—Betamethasone—hematologic cancer	0.00141	0.00141	CcSEcCtD
Guaifenesin—Dizziness—Dexamethasone—hematologic cancer	0.00141	0.00141	CcSEcCtD
Guaifenesin—Nausea—Triamcinolone—hematologic cancer	0.0014	0.0014	CcSEcCtD
Guaifenesin—Discomfort—Doxorubicin—hematologic cancer	0.00139	0.00139	CcSEcCtD
Guaifenesin—Vomiting—Dexamethasone—hematologic cancer	0.00136	0.00136	CcSEcCtD
Guaifenesin—Vomiting—Betamethasone—hematologic cancer	0.00136	0.00136	CcSEcCtD
Guaifenesin—Rash—Dexamethasone—hematologic cancer	0.00135	0.00135	CcSEcCtD
Guaifenesin—Rash—Betamethasone—hematologic cancer	0.00135	0.00135	CcSEcCtD
Guaifenesin—Dermatitis—Dexamethasone—hematologic cancer	0.00134	0.00134	CcSEcCtD
Guaifenesin—Dermatitis—Betamethasone—hematologic cancer	0.00134	0.00134	CcSEcCtD
Guaifenesin—Headache—Dexamethasone—hematologic cancer	0.00134	0.00134	CcSEcCtD
Guaifenesin—Headache—Betamethasone—hematologic cancer	0.00134	0.00134	CcSEcCtD
Guaifenesin—Nausea—Betamethasone—hematologic cancer	0.00127	0.00127	CcSEcCtD
Guaifenesin—Nausea—Dexamethasone—hematologic cancer	0.00127	0.00127	CcSEcCtD
Guaifenesin—Urticaria—Methotrexate—hematologic cancer	0.00123	0.00123	CcSEcCtD
Guaifenesin—Dizziness—Prednisone—hematologic cancer	0.00123	0.00123	CcSEcCtD
Guaifenesin—Vomiting—Prednisone—hematologic cancer	0.00118	0.00118	CcSEcCtD
Guaifenesin—Rash—Prednisone—hematologic cancer	0.00117	0.00117	CcSEcCtD
Guaifenesin—Dermatitis—Prednisone—hematologic cancer	0.00117	0.00117	CcSEcCtD
Guaifenesin—Headache—Prednisone—hematologic cancer	0.00116	0.00116	CcSEcCtD
Guaifenesin—Urticaria—Epirubicin—hematologic cancer	0.00115	0.00115	CcSEcCtD
Guaifenesin—Nausea—Prednisone—hematologic cancer	0.0011	0.0011	CcSEcCtD
Guaifenesin—Urticaria—Doxorubicin—hematologic cancer	0.00107	0.00107	CcSEcCtD
Guaifenesin—Dizziness—Methotrexate—hematologic cancer	0.00103	0.00103	CcSEcCtD
Guaifenesin—Vomiting—Methotrexate—hematologic cancer	0.000988	0.000988	CcSEcCtD
Guaifenesin—Rash—Methotrexate—hematologic cancer	0.00098	0.00098	CcSEcCtD
Guaifenesin—Dermatitis—Methotrexate—hematologic cancer	0.000979	0.000979	CcSEcCtD
Guaifenesin—Headache—Methotrexate—hematologic cancer	0.000973	0.000973	CcSEcCtD
Guaifenesin—Dizziness—Epirubicin—hematologic cancer	0.000961	0.000961	CcSEcCtD
Guaifenesin—Vomiting—Epirubicin—hematologic cancer	0.000924	0.000924	CcSEcCtD
Guaifenesin—Nausea—Methotrexate—hematologic cancer	0.000923	0.000923	CcSEcCtD
Guaifenesin—Rash—Epirubicin—hematologic cancer	0.000917	0.000917	CcSEcCtD
Guaifenesin—Dermatitis—Epirubicin—hematologic cancer	0.000916	0.000916	CcSEcCtD
Guaifenesin—Headache—Epirubicin—hematologic cancer	0.000911	0.000911	CcSEcCtD
Guaifenesin—Dizziness—Doxorubicin—hematologic cancer	0.00089	0.00089	CcSEcCtD
Guaifenesin—Nausea—Epirubicin—hematologic cancer	0.000864	0.000864	CcSEcCtD
Guaifenesin—Vomiting—Doxorubicin—hematologic cancer	0.000855	0.000855	CcSEcCtD
Guaifenesin—Rash—Doxorubicin—hematologic cancer	0.000848	0.000848	CcSEcCtD
Guaifenesin—Dermatitis—Doxorubicin—hematologic cancer	0.000847	0.000847	CcSEcCtD
Guaifenesin—Headache—Doxorubicin—hematologic cancer	0.000843	0.000843	CcSEcCtD
Guaifenesin—Nausea—Doxorubicin—hematologic cancer	0.000799	0.000799	CcSEcCtD
